- Home
- FUND vs NBTX Comparison
FUND vs NBTX Comparison
Compare FUND & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUND
- NBTX
- Stock Information
- Founded
- FUND 1988
- NBTX 2003
- Country
- FUND Canada
- NBTX France
- Employees
- FUND N/A
- NBTX N/A
- Industry
- FUND Investment Managers
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- FUND Finance
- NBTX Health Care
- Exchange
- FUND Nasdaq
- NBTX Nasdaq
- Market Cap
- FUND 236.5M
- NBTX 201.9M
- IPO Year
- FUND N/A
- NBTX 2020
- Fundamental
- Price
- FUND $7.51
- NBTX $2.87
- Analyst Decision
- FUND
- NBTX Strong Buy
- Analyst Count
- FUND 0
- NBTX 1
- Target Price
- FUND N/A
- NBTX $12.00
- AVG Volume (30 Days)
- FUND 32.5K
- NBTX 45.1K
- Earning Date
- FUND 01-01-0001
- NBTX 09-18-2024
- Dividend Yield
- FUND 6.64%
- NBTX N/A
- EPS Growth
- FUND N/A
- NBTX N/A
- EPS
- FUND 0.93
- NBTX N/A
- Revenue
- FUND N/A
- NBTX $45,220,186.00
- Revenue This Year
- FUND N/A
- NBTX N/A
- Revenue Next Year
- FUND N/A
- NBTX N/A
- P/E Ratio
- FUND $8.33
- NBTX N/A
- Revenue Growth
- FUND N/A
- NBTX 526.17
- 52 Week Low
- FUND $6.75
- NBTX $2.76
- 52 Week High
- FUND $8.47
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- FUND 48.96
- NBTX 37.64
- Support Level
- FUND $7.29
- NBTX $2.82
- Resistance Level
- FUND $7.56
- NBTX $3.07
- Average True Range (ATR)
- FUND 0.07
- NBTX 0.20
- MACD
- FUND 0.03
- NBTX 0.02
- Stochastic Oscillator
- FUND 85.71
- NBTX 10.42
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.